Cipher Capital’s Bio-Techne TECH Stock Holding History

Cipher Capital’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-29,328	Closed	-$2.18M	–	704
2023 Q1	$2.18M	Buy	29,328 +23,903	+441%	+$1.84M	0.4%	63
2022 Q4	$450K	Buy	+5,425	New	+$431K	0.08%	307

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Cipher Capital's TECH Position: Q2 2023 in Review

Cipher Capital sold out of Bio-Techne (TECH) in Q2 2023, closing a stake of 29,328 shares — an estimated $2.18M sold.

Cipher Capital first reported a position in TECH in Q4 2022 and held it in 2 quarters. The position peaked at $2.18M in Q1 2023. 528 funds tracked by Wall St. Rank hold TECH as of Q2 2023.

Cipher Capital reported no remaining Bio-Techne position as of Q2 2023 after selling out during the quarter.
Cipher Capital sold 29,328 Bio-Techne shares in Q2 2023, an estimated $2.18M.
Cipher Capital first reported a position in Bio-Techne in Q4 2022 and held it in 2 quarters.
Cipher Capital's Bio-Techne position peaked at $2.18M in Q1 2023.
528 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2023.

Based on Cipher Capital's 13F filing for Q2 2023, filed 14 Aug 2023.